deltatrials

Non-Hodgkin lymphoma Trials in Chicago, United States

Conditions / Non-Hodgkin lymphoma / Chicago, United States

Research into Non-Hodgkin lymphoma spans multiple therapeutic approaches and trial phases.

31 total trials for this combination

Showing top 10 of 31 trials

Trials

NCT ID Title Status Phase
NCT06418204 Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics RECRUITING
NCT03454451 CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers COMPLETED PHASE1
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry RECRUITING
NCT00332202 PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin COMPLETED PHASE3
NCT04771572 Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. RECRUITING PHASE1
NCT03570892 Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma ACTIVE_NOT_RECRUITING PHASE3
NCT01000753 Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma COMPLETED
NCT01351545 A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) RECRUITING
NCT00341705 The Second Multicenter Hemophilia Cohort Study COMPLETED
NCT01777152 ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas COMPLETED PHASE3

Related Pages